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Most newly synthesized peroxisomal matrix proteins
are transported to the organelle by Pex5p, a remarkable
multidomain protein involved in an intricate network of
transient protein-protein interactions. Presently, our
knowledge regarding the structure/function of amino
acid residues 118 to the very last residue of mammalian
Pex5p is quite vast. Indeed, the cargo-protein receptor
domain as well as the binding sites for several peroxins
have all been mapped to this region of Pex5p. In con-
trast, structural/functional data regarding the first 117
amino acid residues of Pex5p are still scarce. Here we
show that a truncated Pex5p lacking the first 110 amino
acid residues (N110-Pex5p) displays exactly the perox-
isomal import properties of the full-length peroxin im-
plying that this N-terminal domain is involved neither
in cargo-protein binding nor in the docking/transloca-
tion step of the Pex5p-cargo protein complex at the per-
oxisomal membrane. However, the ATP-dependent ex-
port step of N110-Pex5p from the peroxisomal
membrane is completely blocked, a phenomenon that
was also observed for a Pex5p version lacking just the
first 17 amino acid residues but not for a truncated
protein comprising amino acid residues 1–324 of Pex5p.
By exploring the unique properties of N110-Pex5p, the
effect of temperature on the import/export kinetics of
Pex5p was characterized. Our data indicate that the
export step of Pex5p from the peroxisomal compartment
(in contrast with its insertion into the organelle mem-
brane) is highly dependent on the temperature.
All peroxisomal matrix proteins are synthesized in the cy-
tosol and post-translationally imported into the organelle. Spe-
cific targeting of these proteins to the peroxisome is promoted
by one of two receptor proteins, the peroxins Pex5p and Pex7p
(reviewed in Refs. 1–4). By far the vast majority of peroxisomal
matrix proteins use Pex5p as their import receptor. Proteins
belonging to this family possess a peroxisomal targeting signal
type 1 (PTS1),1 a C-terminal tripeptide with the sequence SKL,
or a conserved variant (5–7). A very small group of peroxisomal
matrix proteins is targeted to the organelle by Pex7p. This
peroxin recognizes a degenerated nona-peptide complying to
the consensus sequence (R/K)(L/I/V)X5(H/Q)(L/A/F), the so-
called peroxisomal targeting signal type 2 (PTS2) (8–10). In
mammals and plants, but not in lower eukaryotes, targeting of
these PTS2-containing proteins seems to require Pex5p, sug-
gesting that the two import pathways actually converge at the
level of the PTS1 receptor (11–21).
The Pex5p-mediated protein import process can be divided
into four major steps (reviewed in Refs. 1–4). In the first step,
newly synthesized peroxisomal proteins interact with their
receptor while still in the cytosol. The molecular basis for this
interaction is now well defined. Indeed, both structural and
biochemical studies have shown that the seven tetratricopep-
tide repeats present in the C-terminal half of Pex5p provide the
binding site for the PTS1 sequence (7, 22–27). In the second
step, these soluble cargo protein-Pex5p complexes are recog-
nized by a complex protein machinery present at the peroxiso-
mal membrane. Although the exact composition and architec-
ture of this machinery are still ill defined, recent protein
purification studies suggest that Pex2p, Pex10p, Pex12p,
Pex13p (see “Discussion”), and Pex14p are the core components
of this protein complex (28–30). Somewhere during or imme-
diately after this recognition event, cargo proteins are translo-
cated across the membrane of the peroxisome (step 3). There is
still some controversy regarding the fate of Pex5p during this
step. Indeed, some authors have proposed that Pex5p is com-
pletely translocated across the organelle membrane together
with the cargo proteins (31, 32). However, data suggesting that
Pex5p stays in contact with the peroxisomal membrane during
this step are also available (see below and Ref. 33). Finally,
Pex5p is recycled (exported) back to the cytosol in order to
catalyze further rounds of transportation (step 4). Besides the
fact that ATP hydrolysis is required at this stage (34), not much
is known regarding this step.
Thus, although the data supporting this general model are
now abundant (35–37), it is clear that we are still far from
understanding the mechanistic details of this process. Much of
what we know regarding this issue has been inferred from
steady-state level analysis of peroxisomal Pex5p in several
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mutant cell lines (35, 36). It is true that this type of studies has
been quite valuable in assigning general functions to compo-
nents involved in protein translocation across the peroxisomal
membrane. However, it is also evident that different experi-
mental strategies have to be used in order to characterize in
detail the mechanism of this process.
We have recently described an in vitro system particularly
suited to study the process of association (import)/dissociation
(export) of Pex5p with and from the peroxisomal compartment.
It consists of incubating 35S-labeled Pex5p with a post-nuclear
supernatant from rat liver, and it explores the fact that Pex5p
acquires a protease-resistant status when inserted into the
peroxisomal membrane (38, 39). By using this experimental
strategy, it was shown that insertion of Pex5p into the perox-
isomal membrane requires the presence of PTS1-containing
proteins in the import medium and depends on available
Pex14p, an intrinsic membrane component of the peroxisomal
docking/translocation machinery (39, 40). Unexpectedly, inser-
tion of Pex5p into the organelle membrane does not require
ATP, suggesting that the driving force for protein translocation
across the peroxisomal membrane resides on protein-protein
interactions. In contrast, export (recycling) of Pex5p from the
peroxisomal compartment is ATP-dependent (34). At the per-
oxisomal membrane level, two different populations of Pex5p
could be identified and characterized using protease-protection
assays (39). In the presence of ATP, conditions in which Pex5p
continuously enters and exits the peroxisomal membrane, per-
oxisomal Pex5p behaves as a transmembrane protein exposing
the majority of its mass into the peroxisomal lumen with only
a small N-terminal fragment of 2 kDa accessible to the pro-
tease from the cytosolic side of the membrane. This is the
so-called stage 2 Pex5p. Under ATP-limiting conditions or in
the presence of nonhydrolyzable ATP analogues, a second
membrane population of Pex5p is observed. This population of
Pex5p, referred to as stage 3 Pex5p, is completely resistant to
the protease as long as the organelles are kept intact. It was
also shown that stage 2 is the precursor of stage 3 Pex5p and
that this population of Pex5p leaves the peroxisomal mem-
brane rapidly in the presence of ATP. Most interestingly, both
stage 2 and stage 3 Pex5p can be immunoprecipitated by anti-
Pex14p antibodies. These observations led to the proposal that
Pex14p remains in contact with Pex5p during most of the steps
(if not all) occurring at the peroxisomal membrane, a conclu-
sion that is in perfect agreement with the protein purification
studies cited above (28–30).
Here we have used this in vitro system to characterize the
role of the first 110 amino acid residues of Pex5p. By using
several criteria, it is shown that a truncated version of Pex5p
lacking this domain displays exactly the peroxisomal import
properties of the full-length version of the peroxin, implying
that this domain is necessary neither for cargo-protein binding
nor for insertion into the peroxisomal membrane. However, in
contrast to full-length Pex5p, N-terminal truncated Pex5p is
unable to exit the peroxisomal compartment. By using the
unique properties of this truncated version of Pex5p we have
characterized the import/export kinetics of full-length Pex5p.
MATERIALS AND METHODS
Rat liver post-nuclear supernatants (PNS) and peroxisomes were
prepared as described before (34) in SEM buffer (0.25 M sucrose, 20 mM
MOPS-KOH, pH 7.4, 1 mM EDTA-NaOH, pH 7.4) supplemented with 2
g/ml N-(trans-epoxysuccinyl)-L-leucine 4-guanidinobutylamide. In
vitro import experiments using PNS or purified peroxisomes were per-
formed in import buffer (0.25 M sucrose, 50 mM KCl, 20 mM MOPS-
KOH, pH 7.4, 3 mM MgCl2, 0.2% (w/v) lipid-free bovine serum albumin,
20 M methionine, and 2 g/ml N-(trans-epoxysuccinyl)-L-leucine
4-guanidinobutylamide). Import reactions were performed in a 100-l
final volume using 150 g of PNS protein, unless indicated otherwise.
Where specified, an ATP-regenerating system (10 mM creatine phos-
phate and creatine phosphokinase 5 units/ml, final concentrations) was
included in the import reactions. With this modification the Pex5p
export activity of peroxisomes is maintained for longer periods (45
min; data not shown). Proteinase K treatment of import reactions and
processing of protein samples for SDS-PAGE and autoradiography were
done exactly as described (39).
The cDNAs encoding full-length human Pex5p (the large isoform;
Ref. 11) or the C-terminal truncated version comprising amino acid
residues 1–324 of Pex5p (C1-Pex5p) preceded by the T7 RNA
polymerase promotor were obtained as described previously (39, 40).
The cDNAs encoding the N-terminal truncated versions of Pex5p lack-
ing the first 17 or the first 110 amino acid residues (N17-Pex5p and
N110-Pex5p, respectively) were obtained by using an expression PCR
strategy (41). In the first PCR, the pGEM4-Pex5p plasmid (39) was
amplified by using the forward primers 5-GAGCCACCATGAAGCTC-
GCCGGGCACT-3 (for N17-Pex5p) or 5-GACCCACCATGGACTTG-
GCCTTGTCTGAGAACTGG-3 (for N110-Pex5p) and the reverse
primer 5-GAGACTGTCACTGGGGCAGGCCAAACATAG-3. In the sec-
ond PCRs, this reverse primer was used together with the forward
primer 5-GAATTCTAATACGACTCACTATAGGGAGAGCCACCATG-
3. cDNAs were subjected to in vitro transcription using T7 RNA po-
lymerase (Roche Applied Science). 35S-Labeled proteins were synthe-
sized using the translation kit Retic Lysate IVTTM (Ambion) in the
presence of RedivueTM L-[35S]methionine (specific activity 1000 Ci/
mmol) following the manufacturer’s instructions. In antibody inhibition
experiments, 150 g of rat liver PNS or 80 g of purified peroxisomes
were preincubated with 30 g of nonimmune or anti-Pex14p immuno-
globulins (29) or 10 g of nonimmune or anti-Pex13p (42) Fab frag-
ments in 100 l of import buffer for 20 min on ice, before starting the
import reaction by adding the radiolabeled proteins.
The synthesis and purification of glutathione S-transferase (GST), a
recombinant protein comprising GST fused to amino acid residues
312–639 of Pex5p (GST-TPRs; Ref. 40), GST-Pex5p (39), GST-SKL
(GST containing a PTS1 signal at the C terminus; Ref. 40), and GST-
LKS (GST ending with a nonfunctional PTS1-like sequence; Ref. 40)
were described before. These recombinant proteins were used in import
reactions at final concentrations of 0.17 M (GST and GST-TPRs), 0.85
M (GST-Pex5p), and 8 M (GST-SKL and GST-LKS).
IgGs were purified from rabbit sera using protein A-Sepharose
beads according to the manufacturer (Amersham Biosciences). Prep-
aration of Fab fragments using immobilized papain was carried out
using the ImmunoPure Fab preparation kit (Pierce). Densitometric
analysis of x-ray films was performed using the UNSCAN-IT auto-
mated digitizing system.
RESULTS
Pex5p Lacking the First 110 Amino Acid Residues Is Effi-
ciently Targeted to the Peroxisomal Compartment—The large
isoform of mammalian Pex5p (hereafter referred to as Pex5p;
Ref. 11) is a remarkable multidomain protein of 639 amino acid
residues involved in a complex network of transient protein-
protein interactions. Presently, our knowledge on the struc-
ture/function of amino acid residues 118–639 of mammalian
Pex5p is quite vast. Indeed, a variety of biochemical and struc-
tural studies have shown that this region of the protein con-
tains the binding site for PTS1-containing cargo proteins (7,
22–27), seven Pex14p-binding domains (43–45), and binding
sites for Pex7p (11–14), Pex12p (46), and Pex13p (45). In sharp
contrast, not much is known regarding the role of the first 117
amino acid residues of Pex5p. That this domain is important for
the function of Pex5p in vivo was recently shown (45). However,
the reason behind this observation remains unclear. In order to
address this issue, we have used an in vitro import system to
compare the properties of a truncated version of Pex5p lacking
the first 110 amino acid residues (N110-Pex5p) with the ones
displayed by the full-length peroxin.
When 35S-labeled full-length Pex5p is subjected to an import
reaction in the absence of exogenous nucleotides, two different
peroxisomal membrane populations of the peroxin are detected
upon protease treatment of the import reactions (Fig. 1A, lane
1). These correspond to stage 2 Pex5p (the faster migrating
band) and stage 3 Pex5p (see Introduction). In the presence of
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exogenous ATP, stage 2 Pex5p is by far the most prominent
population (Fig. 1A, lane 2). In the presence of ATPS, the two
membrane populations of Pex5p are again detected (Fig. 1A,
lane 3). However, the levels of these populations are decreased
when compared with those detected in the absence of exoge-
nous ATP. It should be noted that this phenomenon does not
reflect the need for ATP during the import step of Pex5p. It was
recently shown that this step is ATP-independent (34). This
difference is related to the fact that import reactions performed
in the absence of exogenous ATP do contain some ATP (from
both the PNS fraction and reticulocyte lysate). This endoge-
nous ATP promotes some degree of export of rat liver Pex5p
from the docking/translocation sites thus freeing these sites for
the 35S-labeled Pex5p. When the results obtained with N110-
Pex5p are analyzed, two major differences are evident. The
first is that in the absence of exogenous ATP (lane 4) or in the
presence of ATPS (Fig. 1A, lane 6), it is no longer possible to
detect two protease-resistant populations. Please note that the
difference between stage 2 and stage 3 Pex5p is that only the
former can be cleaved by proteinase K, a cleavage that occurs
around amino acid residues 15–20 (39). Obviously, in the ab-
sence of this domain, as it is the case for N110-Pex5p, no
cleavage can occur. Thus, this result is in perfect agreement
with the proposed membrane topology for stage 2 Pex5p (39).
The second difference regards the relative amount of N110-
Pex5p detected in the absence (lane 4) and presence (lane 5) of
exogenous ATP. When this ratio is compared with the one
obtained for the full-length peroxin, it is clear that more pro-
tease-resistant N110-Pex5p than full-length Pex5p can be
obtained in an import reaction containing exogenous ATP. The
reason behind this observation is explained below.
As described previously, insertion of full-length Pex5p into
the peroxisomal membrane requires the existence of PTS1-
containing proteins in the import medium. If these PTS1 cargo
proteins are sequestered from the medium by adding an excess
of a recombinant protein comprising the receptor domain of
Pex5p but not its peroxisomal targeting domain (GST-TPRs),
then insertion of Pex5p into the organelle membrane is no
longer observed (40). We used this strategy to characterize
further the import properties of N110-Pex5p. As shown in Fig.
1B, insertion of N110-Pex5p into the peroxisomal membrane
is blocked when GST-TPRs is added to the import reaction
(lanes 4 and 5). However, this inhibitory effect is suppressed in
the presence of an excess of a recombinant PTS1-containing
protein (Fig. 1B, lane 6). Thus, insertion of N110-Pex5p into
the peroxisomal membrane is cargo protein-dependent.
Another criterion currently used to demonstrate the speci-
ficity of this in vitro system relies on the use of an antibody
directed to Pex14p. Preincubation of PNS fractions with this
antibody decreases the amount of Pex5p that is inserted into
peroxisomal membrane (39). This observation corroborates pre-
vious findings showing that the import of a PTS1-containing
protein is also blocked in the presence of anti-Pex14p IgGs (47).
Thus, we tested the inhibitory effect of anti-Pex14p IgGs on the
membrane insertion process of N110-Pex5p. As shown in Fig.
1C, the amount of protease-resistant N110-Pex5p decreases
when the PNS fraction is preincubated with the anti-Pex14p
antibody (Fig. 1C, compare lanes 1 and 2 with lane 3).
Exactly the same inhibition can be observed when IgGs (data
not shown) or Fab fragments directed to Pex13p are used in
these in vitro experiments. The insertion of either Pex5p or
N110-Pex5p into the peroxisomal membrane is highly inhib-
ited (Fig. 1D, compare lanes 1 and 2 with lane 3). Most impor-
tantly, this inhibitory effect of anti-Pex13p Fab fragments is
still observed when these two radiolabeled proteins are subject
to import reactions using purified rat liver peroxisomes (Fig.
1D, compare lanes 4 and 5 with lane 6). As described recently,
isolated peroxisomes are not functional in catalyzing the export
of Pex5p back to the cytosolic compartment (34). Thus, this
result indicates that most (if not all) active docking/transloca-
tion sites of the peroxisomal membrane contain Pex13p (see
“Discussion”).
Taken together, these data indicate that insertion of N110-
Pex5p into the peroxisomal membrane is as specific as the
insertion of the full-length peroxin. In addition, these data
allow us to conclude that the first 110 amino acid residues of
Pex5p do not play any crucial role in either cargo-protein bind-
ing or in the docking/translocation step of the Pex5p-cargo
protein complex at the peroxisomal membrane.
Peroxisomal N110-Pex5p Is Not a Substrate for the Peroxi-
somal Recycling Machinery—As noted above, the amount of
protease-protected N110-Pex5p obtained upon in vitro im-
port experiments in the presence of exogenous ATP is re-
markably higher than the one observed for the full-length
peroxin. Considering that under these conditions full-length
Pex5p enters and exits the peroxisomal membrane (34), this
observation immediately suggested to us that the export step
of N110-Pex5p from the peroxisomal membrane could some-
how be abnormal. To test this hypothesis, an in vitro pulse-
FIG. 1. Pex5p lacking the first 110 amino acid residues is cor-
rectly targeted to the peroxisomal membrane. A, PNS fractions
were incubated for 45 min with 35S-labeled Pex5p (lanes 1–3) or 35S-
labeled N110-Pex5p (lanes 4–6) in import buffer containing no exog-
enous nucleotides (lane 1 and 4), 5 mM ATP (lane 2 and 5), or 5 mM
ATPS (lane 3 and 6). Lanes Ly1 and Ly2, 35S-labeled Pex5p and
35S-labeled N110-Pex5p, respectively, used in the import reactions
(5% of input). B, in vitro synthesized Pex5p or N110-Pex5p were
incubated with PNS fractions in import buffer containing 5 mM ATP in
the presence of 0.17 M GST (lanes 1–3) or GST-TPRs (lanes 4–6).
GST-LKS (lanes 2 and 5) or GST-SKL (lanes 3 and 6) fusion proteins
were also included in the import reactions (8 M final concentrations).
C, PNS fractions were incubated for 20 min on ice with nonimmune
IgGs (lane 2), anti-Pex14p IgGs (lane 3), or in the absence of IgGs (lane
1) and subjected to an import reaction with 35S-labeled Pex5p or N110-
Pex5p in the absence of exogenous nucleotides. D, PNS fractions or
purified peroxisomes were preincubated 20 min on ice with nonimmune
Fab fragments (lane 2 and 5), anti-Pex13p Fab fragments (lane 3 and 6),
or in the absence of Fab fragments (lane 1 and 4) and were subjected to
an import reaction with 35S-labeled Pex5p or 35S-labeled N110-Pex5p
in the absence of exogenous nucleotides. Per, purified peroxisomes.
Lanes Ly, 35S-labeled Pex5p (upper panels) and 35S-labeled N110-
Pex5p (lower panels) used in the in vitro reactions (5% of input). All
the in vitro reactions were performed at 26 °C, treated with proteinase
K and analyzed by SDS-PAGE autoradiography.
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chase import experiment was performed (39). Besides full-
length Pex5p and N110-Pex5p, a C-terminal truncated
protein comprising amino acid residues 1–324 of Pex5p (C1-
Pex5p) was also included in this analysis. The import (but not
the export) properties of C1-Pex5p were described before
(40). 35S-Labeled Pex5p, N110-Pex5p, or C1-Pex5p were
separately incubated with a PNS fraction for 15 min in the
absence of exogenous ATP. At this time, a vast excess of
recombinant GST-Pex5p was added to the import reactions to
block further import of the 35S-labeled proteins. Seven min
later, an aliquot of each import reaction was taken (Fig. 2,
lane 1), and immediately, ATP (5 mM) was added to the
reactions. Aliquots were removed 8 (Fig. 2, lane 2) and 23 min
later (lanes 3). As expected, the amount of peroxisomal 35S-
labeled Pex5p decreases over time indicating that Pex5p is
capable of exiting the peroxisomal membrane (39). A similar
result was obtained for C1-Pex5p. In contrast, the amount
of protease-protected N110-Pex5p remains constant during
the complete incubation time indicating that, indeed, N110-
Pex5p is unable to exit the peroxisomal compartment.
We have tried to define more precisely the amino acid resi-
dues of Pex5p required for the export step. This proved to be
quite a difficult task. Indeed, several attempts to express in
vitro several N-terminal truncated forms slightly longer than
N110-Pex5p were unsuccessful. Translation of these mRNAs
resulted in either no protein synthesis or in the synthesis of
truncated Pex5p products migrating faster than N110-Pex5p
upon SDS-PAGE (data not shown). Only in the last part of this
work did we manage to obtain a correct, although weak, in vitro
expression when using an mRNA coding for a truncated form of
Pex5p lacking just the first 17 amino acid residues (N17-
Pex5p). The export competence of this protein was then as-
sessed by using the pulse-chase strategy described above. The
results of this analysis are also shown in Fig. 2. The amount of
protease-resistant N17-Pex5p remains constant during the
complete incubation time as observed for N110-Pex5p.
Two conclusions can be drawn from these results. First,
amino acid residues 325–639 (the second half of Pex5p) are not
required for the export step suggesting that this portion of the
PTS1 receptor does not establish crucial interactions with the
peroxisomal export machinery. Second, amino acid residues
18–110 per se are not sufficient to enable peroxisomal Pex5p to
be exported back to the cytosolic fraction.
Import/Export of Pex5p into/from the Peroxisomal Membrane,
Temperature Dependence—We are still far from being able to
describe the Pex5p-mediated process of protein import into
peroxisomes by using defined chemical equations. The com-
plexity of the process is huge, and problems are encountered in
the simple effort of defining the stoichiometry of the Pex5p-
cargo protein interaction (48). Even more obscure is the nature
of the interaction of the Pex5p-cargo protein complex with the
docking/translocation machinery, virtually nothing is known in
the chemical sense (i.e. number of steps, rate constants, etc.).
Our knowledge of the export step of Pex5p from the peroxiso-
mal membrane is not better. It has been shown that ATP
hydrolysis is required at this step (34), but the nature of the
ATPases involved or the need for additional factors is un-
known. Surely one strategy to start addressing all these issues
is to obtain some basic data regarding the kinetics of these
processes. Here the effects of temperature on the peroxisomal
import/export processes of Pex5p are described. Two observa-
tions prompted us to perform this analysis. The first is related
to the finding that in our in vitro system the amount of pro-
tease-protected 35S-labeled Pex5p is maximal at 26 °C, not at
37 °C (39), a more physiological value. The second observation
regards the fact that Pex5p can be accumulated at the peroxi-
somal compartment in vivo just by decreasing the temperature
of the cell cultures (35).
A PNS fraction was incubated at 26 °C for 10 min in the
presence of 5 mM ATP in order to release endogenous Pex5p
from the peroxisomal docking/translocation sites. Equal por-
tions of this PNS fraction were then added to mixtures contain-
ing 35S-labeled Pex5p and N110-Pex5p in import buffer pre-
equilibrated at 16, 26, or 37 °C. The amounts of protease-
protected radiolabeled proteins as function of time in each of
these three reactions were quantified. The results of this ex-
periment are shown in Fig. 3. At 16 °C, a steady increase on the
amounts of protease-protected Pex5p and N110-Pex5p is ob-
served. Most importantly, a graphical representation of the
ratio of Pex5p to N110-Pex5p as function of time yields a
FIG. 2. Peroxisomal export competencies of truncated ver-
sions of Pex5p. In vitro synthesized Pex5p, N110-Pex5p, C1-Pex5p,
and N17-Pex5p were incubated with the PNS fraction (450 g of
protein in a 300-l final volume) in the absence of exogenous ATP for 15
min at 26 °C. A vast excess of recombinant GST-Pex5p was then added
to the reactions to block further insertion of the Pex5p proteins into the
peroxisomal membrane, and 7 min later, an aliquot corresponding to
150 g of PNS protein was removed (lane 1). ATP (5 mM final concen-
tration) was then added to the import reactions. Aliquots of the import
reactions (150 g of PNS protein) were taken 8 and 23 min later (lanes
2 and 3, respectively). All the samples were treated with proteinase K
and analyzed by SDS-PAGE autoradiography. Lanes Ly, radiolabeled
proteins used in the in vitro reactions.
FIG. 3. Export of Pex5p from the peroxisomal compartment,
but not its insertion into the peroxisomal membrane, is blocked
at low temperatures. A PNS fraction (5.4 mg of protein) was incu-
bated at 26 °C for 10 min in 600 l of import buffer containing 5 mM
ATP to release endogenous Pex5p from peroxisomal docking/transloca-
tion sites (34). Equal portions of this PNS fraction (1.8 mg of protein)
were then added to tubes containing a mixture of 35S-labeled Pex5p and
N110-Pex5p in 200 l of import buffer supplemented with 5 mM ATP
and an ATP-regenerating system, pre-equilibrated at 16, 26, or 37 °C.
Aliquots of the three import reactions (corresponding to 450 g of PNS
protein) were removed at the indicated time points, subjected to pro-
teinase K treatment, and analyzed by SDS-PAGE autoradiography.
Lanes Ly1 and Ly2, 35S-labeled Pex5p and 35S-labeled N110-Pex5p,
respectively, used in the import reactions. A densitometric analysis of
protease-resistant Pex5p and N110-Pex5p is also presented. The
Pex5p/N110-Pex5p ratios obtained at 16 (circles), 26 (squares), and
37 °C (triangles) are plotted against time.
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straight line with a slope close to 0. Considering that N110-
Pex5p is unable to exit the peroxisomal compartment, this
result implies that full-length Pex5p is not exported from the
peroxisomal membrane at this temperature. Quite different
results are obtained at 26 or 37 °C. Under these conditions, a
steady increase in the amounts of protease-protected N110-
Pex5p is still observed, as expected. However, the amounts of
protease-protected Pex5p converge to steady-state values very
rapidly, particularly at 37 °C. Accordingly, graphical represen-
tations of these data result in concave curves tending to a zero
value. Exactly the same kinetic behavior was observed for both
Pex5p and N110-Pex5p when these experiments were per-
formed using the radiolabeled proteins separately (data not
shown).
Taken together these data provide the mechanistic explana-
tion for the two observations cited above. By decreasing the
temperature in the in vitro or the in vivo assays, one is prefer-
entially inhibiting the peroxisomal export step of Pex5p. Obvi-
ously, this leads to the accumulation of Pex5p at the peroxiso-
mal compartment.
The results presented in Fig. 3 reveal two other interesting
features of the Pex5p cycling pathway. The first is related to
the export rate of Pex5p from the peroxisomal membrane.
Considering that a constant value for the amount of protease-
protected Pex5p is reached within the first 2.5 min of incuba-
tion at 37 °C, implying that the export flux of Pex5p equals its
import flux, then the half-life of the peroxisomal pool of Pex5p
must be smaller than 2.5 min. The second finding derives from
the results obtained at 16 °C. Although Pex5p is unable to exit
the peroxisomal compartment at this temperature, no signifi-
cant amounts of stage 3 Pex5p are detected under these condi-
tions. This observation suggests that the transition of Pex5p
from stage 2 to stage 3 is temperature-dependent. In order to
confirm this property, the following experiment was performed.
35S-Labeled Pex5p and N110-Pex5p (used here as an internal
control) were incubated with a PNS fraction for 15 min at 26 °C
in the presence of 1 mM ATP. After blocking further import of
the radiolabeled proteins by adding a vast excess of recombi-
nant GST-Pex5p, equal portions of the reaction were trans-
ferred to tubes containing import buffer and ATPS (10 mM
final concentration) pre-equilibrated at 16, 26, or 37 °C. Ali-
quots of the import reactions were removed 8 and 23 min later
and processed for SDS-PAGE. As shown in Fig. 4, incubation of
PNS fractions containing stage 2 Pex5p at 16 °C in the pres-
ence of ATPS does not result in the appearance of stage 3
Pex5p. In contrast, large amounts of stage 3 Pex5p are obtained
at 26 and 37 °C. We conclude that conversion of stage 2 into
stage 3 Pex5p is temperature-dependent.
DISCUSSION
In this work we present mechanistic data regarding the
Pex5p-mediated peroxisomal protein import pathway with em-
phasis on its last step, the ATP-dependent recycling step of
Pex5p. It is shown that the first 110 amino acid residues of
Pex5p are involved neither in cargo-protein binding nor in the
docking/translocation step that occurs at the peroxisomal mem-
brane. From the four experimental criteria used to support this
conclusion (see Fig. 1), one is presented here for the first time
and deserves some comments. This regards the inhibitory ef-
fect of anti-Pex13p antibodies on the peroxisomal import step of
Pex5p. Pex13p is an intrinsic membrane component of the
peroxisomal membrane probably involved in the recycling step
of Pex5p back to the cytosolic compartment (45, 49). In vitro
binding assays and yeast and bacterial two-hybrid experiments
have shown that this peroxin is capable of interacting directly
with Pex14p and Pex5p (50). Although there are no doubts that
in vivo the interaction of Pex13p with Pex5p is transient, the
same cannot be said regarding the Pex13p-Pex14p interaction.
Indeed, when peroxisomal membranes from both rat and yeast
are solubilized with the mild detergent digitonin only substoi-
chiometric amounts of Pex13p can be found in association with
Pex14p (29, 30). Two hypotheses were formulated to explain
these observations: either the Pex13p-Pex14p interaction is too
weak to resist the solubilization procedure or there is in fact a
Pex13p protein complex (lacking Pex14p and other known per-
oxins) playing some still undefined role on the process of pro-
tein translocation across the peroxisomal membrane (30). The
finding that anti-Pex13p Fab fragments block almost com-
pletely the insertion of Pex5p into the peroxisomal membrane
implies that most (if not all) active docking/translocation sites
of the peroxisomal membrane possess Pex13p and, thus,
strongly support the first hypothesis.
Considering all the Pex5p protein interaction data published
until now, the observation that the first 110 amino acid resi-
dues of Pex5p are involved neither in cargo-protein binding nor
in the docking/translocation step is not surprising. Indeed,
N110-Pex5p still contains the cargo protein-binding site as
well as all the binding sites for Pex7p, Pex12p, Pex13p and
Pex14p (reviewed in Refs. 3 and 4). Unexpected, however, is the
observation that N110-Pex5p is not a substrate for the per-
oxisomal export machinery catalyzing the export of Pex5p back
to the cytosol. Two major conclusions can be drawn from this
result. The first regards the insertion step of Pex5p into the
peroxisomal membrane. The fact that the amount of protease-
protected N110-Pex5p remains constant in our pulse-chase
experiments (see Fig. 2) suggests that this step is an irrevers-
ible event. The second conclusion regards the role of Pex5p
itself during the export step. A priori, two different mecha-
nisms leading to the release of Pex5p from the docking/trans-
location machinery could be hypothesized. Pex5p could be a
passive entity in this step, i.e. the ATPase promoting the export
of Pex5p from the peroxisomal membrane could simply disas-
semble the docking/translocation machinery sequestering its
Pex5p-interacting peroxins. Alternatively, Pex5p could play an
active role in this process, e.g. Pex5p could be pulled from the
FIG. 4. Transition of stage 2 Pex5p into stage 3 Pex5p is temper-
ature-dependent. A mixture of 35S-labeled Pex5p and 35S-labeled
N110-Pex5p was incubated with a PNS fraction in import buffer con-
taining 1 mM ATP for 15 min at 26 °C. Recombinant GST-Pex5p was then
added to the reaction, and 7 min later, an aliquot was removed (lane 1).
Equal portions of this reaction were then transferred to tubes containing
import buffer supplemented with ATPS (10 mM final concentration)
pre-equilibrated at 16 (lanes 2 and 3), 26 (lanes 4 and 5), or 37 °C (lanes
6 and 7). Aliquots of the import reactions were taken 8 (lanes 2, 4, and 6)
and 23 min later (lanes 3, 5, and 7). All the samples were treated with
proteinase K and analyzed by SDS-PAGE autoradiography. A densito-
metric analysis of protease-resistant Pex5p is presented in the graphic.
The amounts of protease-resistant Pex5p (stage 2 plus stage 3 Pex5p)
were normalized for the amount of N110-Pex5p present in each lane.
The amount of protease-resistant Pex5p in lane 1 was set to 100%. The
gray portions of the bars represent stage 2 Pex5p; black portions rep-
resent stage 3 Pex5p. Numbers in the x axis refer to the lanes of the
autoradiography.
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docking/translocation machinery by the ATPase. By showing
that a Pex5p domain with no role in the docking/translocation
step is required for the export of Pex5p from the peroxisomal
membrane, our data strongly favor this last possibility.
Experiments aiming at refining the Pex5p residues required
for the export step indicate that residues 18–110 per se are not
sufficient to sustain export of Pex5p from the peroxisomal
membrane. This observation suggests that the first 17 amino
acid residues of Pex5p play a major role in this process. In this
context, it may be relevant to note that, although the N-termi-
nal half of Pex5p is poorly conserved among different species,
the sequence Cys-Xn-Asn-Pro-Leu (where Xn is any 3–9 amino
acid residues) is found at the N termini of most Pex5p proteins
(data not shown). Also interesting is the observation that sim-
ilar motifs (Cys-Xn-Asn-(Ala/Gly)-(Leu/Ala)) are found at the N
termini of Neurospora crassa and Yarrowia lipolytica Pex20p
(19, 20). This peroxin is thought to escort the PTS2 receptor to
the peroxisomal membrane, a role that in mammals and plants
is performed by Pex5p (19–21). Whether this N-terminal do-
main of Pex20p is also crucial for the export of this peroxin
from the docking/translocation machinery remains to be
determined.
The reason why these residues of Pex5p are so important for
its function remains unknown. However, it must be noted that
there are now three independent observations pointing to the
existence of a strong correlation between ATP, an active
ATPase, and the export of Pex5p on one side and the first 15–20
amino acid residues of Pex5p on the other side. The first, as
described here, is the fact that N17-Pex5p is not a substrate
for the export machinery. The second regards the observation
that in our in vitro system, stage 3 Pex5p can only be detected
in the absence of exogenous ATP or in the presence of nonhy-
drolyzable ATP analogues. As suggested recently (39), the dif-
ference between stage 2 and stage 3 Pex5p may reside simply
in a protection effect performed by the ATPase catalyzing the
export step of Pex5p over its first 20 amino acid residues. The
third is that no stage 3 Pex5p can be detected in an incomplete
in vitro system in which full-length Pex5p is not exported from
the peroxisomal membrane. It was proposed that the export
machinery in this in vitro system is either absent or inactive
(34). Thus, all these observations converge to the same possi-
bility, namely that the N terminus of Pex5p provides the bind-
ing site for the ATPase catalyzing its export.
The central role of the N terminus of Pex5p in the export step
is also emphasized by the results obtained with C1-Pex5p.
Although this truncated protein contains only amino acid res-
idues 1–324 of Pex5p, our data show that C1-Pex5p is also a
substrate for the export machinery. This observation implies
that the second half of Pex5p, a region that contains the cargo-
protein binding domain, is not involved in crucial interactions
with the export machinery. Thus, the triggering signal for the
export machinery does not reside in conformational alterations
occurring at the C-terminal half of Pex5p, when the receptor
releases its cargo on the luminal side of the peroxisomal mem-
brane. Instead, such signal emerges from the N terminus of
Pex5p. It is possible that at the end of the translocation step
some of the membrane peroxins in contact with the N terminus
of Pex5p suffer some conformational alterations. These struc-
tural rearrangements could, on the one hand, decrease the
affinity of Pex5p to its cargo and, on the other hand, activate
the ATPase-promoting Pex5p export. Possible candidates to
carry these functions are already available. Pex13p in mam-
mals and Pex13p and/or Pex8p in yeast are components of the
docking/translocation machinery that are probably involved in
late steps of the transport cycle (45, 49, 51). However, a more
direct mechanism is also feasible. It is possible that only at the
end of the translocation step Pex5p presents the stereochemical
properties required by the ATPase.
The kinetics of the export step of Pex5p from the peroxisomal
compartment was also characterized. It is shown that this step
is highly dependent on temperature. A maximum of export
activity was detected at 37 °C, whereas no activity could be
detected at 16 °C. In contrast, insertion of Pex5p into the per-
oxisomal membrane could be detected even at this low temper-
ature. These data provide the mechanistic explanation for the
observation that Pex5p can be accumulated at the peroxisomal
compartment in vivo just by decreasing the temperature of the
cell cultures (35). Accumulation of Pex5p at the peroxisomal
compartment does not result from a direct inhibition of the
translocation step, as suggested earlier, but rather from a block
in the export step of Pex5p. In our in vitro experiments, and
possibly in the in vivo situation, this inhibition occurs at the
step where stage 2 Pex5p is converted into stage 3 Pex5p.
Finally, the results presented here suggest that the export step
of Pex5p from the peroxisomal compartment is quite fast at
37 °C, with the peroxisomal pool of Pex5p displaying a half-life
smaller than 2.5 min.
To conclude, we emphasize that the results and experimental
tools described here pave the way to many new experiments.
By exploring the unique properties of N110-Pex5p, it is now
possible to measure simultaneously the peroxisomal import
and export fluxes of Pex5p. The specific effects of many other
experimental variables on each of these processes can now be
addressed.
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